PS
Peter Salzmann (Chief Executive Officer) filed 6 Form 4 reports in the past 24 months (0 purchases, 6 sales), most often in Immunovant, Inc. (IMVT). The largest single filing was $425K of IMVT (16,692 sh × $25.45, as filed), executed Nov 20 2024. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.1M
shares × price, as filed
Last traded
Apr 16 2025
Filed Apr 17 2025
Median ADV $75.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 24 months
Most traded names
IMVTRecent filings
IMVTSALE
Immunovant, Inc.
View filing →
$124K8,321 sh × $14.89
Exec Apr 16 2025
Filed Apr 17 2025 · 5:30 PM ET IMVTSALE Immunovant, Inc. View filing → $365K
28,094 sh × $12.99
Exec Apr 9 2025
Filed Apr 11 2025 · 5:30 PM ET IMVTSALE Immunovant, Inc. View filing → $322K
15,439 sh × $20.86
Exec Feb 19 2025
Filed Feb 21 2025 · 5:30 PM ET IMVTSALE Immunovant, Inc. View filing → $199K
8,352 sh × $23.81
Exec Jan 15 2025
Filed Jan 17 2025 · 5:30 PM ET IMVTSALE Immunovant, Inc. View filing → $123K
5,105 sh × $24.10
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET IMVTSALE Immunovant, Inc. View filing → $425K
16,692 sh × $25.45
Exec Nov 20 2024
Filed Nov 22 2024 · 5:30 PM ET